(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZITUVIMET

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ZITUVIMET

ST13

US500000097690293

Class

5

Filing

97690293

Registration

7811977

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

05/27/2025

Trademark type

Word

Nice classes

5

Filing date

11/23/2022

Registration date

05/27/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/27/2025

Last transaction

05/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/31/2022

First use in commerce

12/16/2024

Drawing code

4

Owner type

03

Owner location

Pennington, NJ

Examiner

JARAMILLO, JAVIER R

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Zydus Pharmaceuticals (USA) Inc.

Representatives

Anthony J. DiMarino DiMarino, Lehrer & Collazo, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for treating diabetes

Publications

History of USPTO decisions and trademark events.

36 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/27/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/27/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/07/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/07/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/07/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/01/2025

IUAF

USE AMENDMENT FILED

04/30/2025

EISU

TEAS STATEMENT OF USE RECEIVED

04/30/2025

EX4G

SOU EXTENSION 4 GRANTED

04/30/2025

EXT4

SOU EXTENSION 4 FILED

04/30/2025

EEXT

SOU TEAS EXTENSION RECEIVED

04/30/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/03/2025

EX3G

SOU EXTENSION 3 GRANTED

02/02/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/02/2025

EXT3

SOU EXTENSION 3 FILED

11/18/2024

EEXT

SOU TEAS EXTENSION RECEIVED

11/18/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/17/2024

EX2G

SOU EXTENSION 2 GRANTED

04/16/2024

EXT2

SOU EXTENSION 2 FILED

04/16/2024

EEXT

SOU TEAS EXTENSION RECEIVED

04/16/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/03/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/03/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/28/2023

EX1G

SOU EXTENSION 1 GRANTED

10/26/2023

EXT1

SOU EXTENSION 1 FILED

10/26/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/26/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/30/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/04/2023

PUBO

PUBLISHED FOR OPPOSITION

04/04/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/24/2023

DOCK

ASSIGNED TO EXAMINER

02/15/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/28/2022

NWAP

NEW APPLICATION ENTERED

11/26/2022

Continuous trademark protection

Get notified about every new filing that threatens ZITUVIMET or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.